Get started
UROGEN PHARMA LTD COM ILS0.01UROGEN PHARMA LTD COM ILS0.01UROGEN PHARMA LTD COM ILS0.01

UROGEN PHARMA LTD COM ILS0.01

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0XOD chart


Full chart

0XOD upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪513.79 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.3 USD
Net income (FY)
‪−102.24 M‬ USD
Revenue (FY)
‪82.71 M‬ USD
Shares float
‪38.20 M‬
Beta (1Y)
1.42

Employees


Employees (FY)
201
Change (1Y)
+1 +0.50%
Revenue / Employee (1Y)
‪411.51 K‬ USD
Net income / Employee (1Y)
‪−508.68 K‬ USD

About UroGen Pharma Ltd.


Sector
Health Technology
Industry
Biotechnology
CEO
Elizabeth Barrett
Website
urogen.com
Headquarters
Princeton
Founded
2004
ISIN
IL0011407140
FIGI
BBG00LN961M5
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

0XOD news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0XOD is 12.1 USD — it has decreased by −0.54% in the past 24 hours. Watch UROGEN PHARMA LTD COM ILS0.01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange UROGEN PHARMA LTD COM ILS0.01 stocks are traded under the ticker 0XOD.
0XOD stock has fallen by −1.37% compared to the previous week, the month change is a −3.19% fall, over the last year UROGEN PHARMA LTD COM ILS0.01 has showed a 5.18% increase.
We've gathered analysts' opinions on UROGEN PHARMA LTD COM ILS0.01 future price: according to them, 0XOD price has a max estimate of 64.00 USD and a min estimate of 22.00 USD. Watch 0XOD chart and read a more detailed UROGEN PHARMA LTD COM ILS0.01 stock forecast: see what analysts think of UROGEN PHARMA LTD COM ILS0.01 and suggest that you do with its stocks.
0XOD reached its all-time high on Jan 4, 2019 with the price of 51.2 USD, and its all-time low was 5.9 USD and was reached on May 11, 2022. View more price dynamics on 0XOD chart.
See other stocks reaching their highest and lowest prices.
0XOD stock is 4.27% volatile and has beta coefficient of 1.42. Track UROGEN PHARMA LTD COM ILS0.01 stock price on the chart and check out the list of the most volatile stocks — is UROGEN PHARMA LTD COM ILS0.01 there?
Today UROGEN PHARMA LTD COM ILS0.01 has the market capitalization of ‪502.42 M‬, it has increased by 7.60% over the last week.
Yes, you can track UROGEN PHARMA LTD COM ILS0.01 financials in yearly and quarterly reports right on TradingView.
UROGEN PHARMA LTD COM ILS0.01 is going to release the next earnings report on Nov 6, 2024. Keep track of upcoming events with our Earnings Calendar.
0XOD earnings for the last quarter are −0.91 USD per share, whereas the estimation was −0.83 USD resulting in a −9.38% surprise. The estimated earnings for the next quarter are −0.82 USD per share. See more details about UROGEN PHARMA LTD COM ILS0.01 earnings.
UROGEN PHARMA LTD COM ILS0.01 revenue for the last quarter amounts to ‪21.85 M‬ USD, despite the estimated figure of ‪23.97 M‬ USD. In the next quarter, revenue is expected to reach ‪24.20 M‬ USD.
0XOD net income for the last quarter is ‪−33.40 M‬ USD, while the quarter before that showed ‪−32.29 M‬ USD of net income which accounts for −3.46% change. Track more UROGEN PHARMA LTD COM ILS0.01 financial stats to get the full picture.
No, 0XOD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 201.00 employees. See our rating of the largest employees — is UROGEN PHARMA LTD COM ILS0.01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UROGEN PHARMA LTD COM ILS0.01 EBITDA is ‪−78.23 M‬ USD, and current EBITDA margin is −77.17%. See more stats in UROGEN PHARMA LTD COM ILS0.01 financial statements.
Like other stocks, 0XOD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UROGEN PHARMA LTD COM ILS0.01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So UROGEN PHARMA LTD COM ILS0.01 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating UROGEN PHARMA LTD COM ILS0.01 stock shows the sell signal. See more of UROGEN PHARMA LTD COM ILS0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.